Based on the findings of a recent clinical trial, long-term projections indicated that exenatide is likely to be associated with improvement in life expectancy and quality-adjusted life expectancy compared to insulin glargine. The results from this modelling analysis suggest that that exenatide is likely to represent good value for money by generally accepted standards in the UK setting in individuals with type 2 diabetes inadequately controlled on oral therapy.

Treatment with analogue insulin was associated with a decreased incidence of long-term complications and improved QALE, but slightly higher treatment costs compared to human insulin therapy. Analogue insulin treatment had an ICER within the range generally considered to represent good value for money in the UK.

Page 207. Under Neuromuscular Pharmacology, sentence 1, line 3, "or" should be replaced with "and": Rhesus monkeys (adult males, 8-15 kg) were anesthetized with ketamine (5 mg/kg, im) and sodium pentobarbital (2-5 mg/kg, iv).

No abstract

No abstract